These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 23507058)
1. Quality of life and outcome measures in vasculitis. Tomasson G Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):69-77. PubMed ID: 23507058 [TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053 [TBL] [Abstract][Full Text] [Related]
8. [Uptodate in the management and treatment of ANCA-associated vasculitis]. Belaconi IN; Toma CL; Bogdan MA Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554 [TBL] [Abstract][Full Text] [Related]
9. Assessment of systemic vasculitis. Miller A; Basu N; Luqmani R Autoimmun Rev; 2008 Dec; 8(2):170-5. PubMed ID: 18672099 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes. Wiik A Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973 [TBL] [Abstract][Full Text] [Related]
12. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment. Ríhová Z; Jancová E; Merta M; Tesar V Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551 [TBL] [Abstract][Full Text] [Related]
13. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. Merkel PA; Seo P; Aries P; Neogi T; Villa-Forte A; Boers M; Cuthbertson D; Felson DT; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer J; Mahr A; Matteson EL; Specks U; Luqmani R; Stone J; ; J Rheumatol; 2005 Dec; 32(12):2488-95. PubMed ID: 16331794 [TBL] [Abstract][Full Text] [Related]
14. [VASCULITIDES IN CHILDHOOD]. Jelušić M; Frković M Reumatizam; 2016; 63 Suppl 1():80-5. PubMed ID: 29624307 [TBL] [Abstract][Full Text] [Related]
15. Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Ponte C; Sznajd J; O'Neill L; Luqmani RA Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-118-25. PubMed ID: 25365100 [TBL] [Abstract][Full Text] [Related]
16. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12. Aydin SZ; Direskeneli H; Sreih A; Alibaz-Oner F; Gul A; Kamali S; Hatemi G; Kermani T; Mackie SL; Mahr A; Meara A; Milman N; Nugent H; Robson J; Tomasson G; Merkel PA J Rheumatol; 2015 Dec; 42(12):2465-9. PubMed ID: 26077399 [TBL] [Abstract][Full Text] [Related]
17. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395 [TBL] [Abstract][Full Text] [Related]
18. Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse. Morgan MD; Szeto M; Walsh M; Jayne D; Westman K; Rasmussen N; Hiemstra TF; Flossmann O; Berden A; Höglund P; Harper L; Arthritis Res Ther; 2017 Jun; 19(1):129. PubMed ID: 28592297 [TBL] [Abstract][Full Text] [Related]
19. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis. Mukhtyar C; Luqmani R Clin Exp Rheumatol; 2007; 25(6 Suppl 47):120-9. PubMed ID: 18021517 [TBL] [Abstract][Full Text] [Related]